Laserfiche WebLink
DocuSign Envelope ID: EBE28081-13782-41342-BAD13-D8C9313687131B <br />TOXICITY REDUCTION EVALUATION LINES OF INVESTIGATION <br />EXECUTIVE SUMMARY <br />The Toxicity Reduction Evaluation (TRE) performed for the Elk Ridge's Colowyo mine site in January <br />2020 identified three primary technologies to address the whole effluent toxicity (WET) in the discharge <br />waters from East Taylor Pond. These technologies are membrane separation with nanofiltration (NF), <br />bacterial sulfate reduction (BSR), and enhanced evaporation. Further development of these technology <br />options as they relate to the site water quality and conditions has allowed the approach for each option to <br />be refined. <br />Given the known toxicants of sulfate and salinity in the mine water, a nanofiltration (NF) membrane is <br />expected to provide the same results with a lower energy requirement than the previously tested reverse <br />osmosis membrane. The poor evaporative site conditions limit the effectiveness of natural evaporation, <br />thus management of the reject brine from the NF membrane filtration requires enhanced evaporation to <br />optimize the size of the pond. <br />Evaluation of site conditions, with the design intent for a passive approach, suggests that a subgrade <br />system be developed for a BSR bioreactor. This approach includes segregation of surface stormwater <br />from subgrade seeps in addition to installation of a seep water collection system. Subsurface seep <br />collection allows for more consistent flow rates and water temperature in the BSR bioreactor influent. <br />Testing will be required to demonstrate and optimize this technology in a bench -scale test and then in the <br />field. A preliminary conceptual design of the BSR bioreactor is outlined within this document. <br />Cost evaluation of the technology options shows that the BSR bioreactor process has the potential for <br />lower costs over the lifecycle of the project than NF membrane filtration. Implementation of the BSR <br />bioreactor is likely to have a lower capital cost, including treatability testing. There is also significant <br />opportunity to further decrease the investment cost through site investigation and possible optimizations <br />(outlined within this report). Operational cost of the BSR bioreactor is expected to be significantly less <br />than NF membrane filtration stemming largely from the lower labor, reagent, and power requirements. <br />There is some uncertainty as to the ethanol requirement for the targeted sulfate removal, but even at the <br />highest published literature value the operational cost of the BSR bioreactor is expected to be less than <br />half of the operating cost of the NF membrane separation system. Bench and pilot testing of the BSR <br />bioreactor is recommended for future design incorporation. <br />